aTyr Pharma, Inc. Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Pentagon reportedly locked down, hazmat teams responding
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
aTyr Pharma (LIFE) IPO Opens Lower
May 7, 2015 11:04 AM EDTToday's IPO for aTyr Pharma (NASDAQ: LIFE) opened for trading at $13.07 after pricing 5,360,000 shares of its common stock at an initial public offering price of $14.00 per share.
J.P. Morgan Securities LLC and Citigroup Global Markets Inc. are acting as joint book-running... More
